These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17339285)

  • 1. Reevaluation of the University of Wisconsin 2-year protocol for treating canine lymphosarcoma.
    Kaiser CI; Fidel JL; Roos M; Kaser-Hotz B
    J Am Anim Hosp Assoc; 2007; 43(2):85-92. PubMed ID: 17339285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and toxicity of doxorubicin/cyclophosphamide maintenance therapy in dogs with multicentric lymphosarcoma.
    Price GS; Page RL; Fischer BM; Levine JF; Gerig TM
    J Vet Intern Med; 1991; 5(5):259-62. PubMed ID: 1748977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of some prognostic factors for advanced multicentric lymphosarcoma in the dog: 147 cases (1978-1981).
    MacEwen EG; Hayes AA; Matus RE; Kurzman I
    J Am Vet Med Assoc; 1987 Mar; 190(5):564-8. PubMed ID: 3558097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy for canine lymphosarcoma.
    Madewell BR
    Am J Vet Res; 1975 Oct; 36(10):1525-8. PubMed ID: 1242622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levamisole as adjuvant to chemotherapy for canine lymphosarcoma.
    MacEwen EG; Hayes AA; Mooney S; Patnaik A; Kurzman I; Hardy WD
    J Biol Response Mod; 1985 Aug; 4(4):427-33. PubMed ID: 3839843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoimmunotherapy for canine lymphosarcoma.
    Theilen GH; Worley M; Benjamini E
    J Am Vet Med Assoc; 1977 Mar; 170(6):607-10. PubMed ID: 576595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carmustine, vincristine, and prednisone in the treatment of canine lymphosarcoma.
    Ricci Lucas SR; Pereira Coelho BM; Marquezi ML; Franchini ML; Miyashiro SI; De Benedetto Pozzi DH
    J Am Anim Hosp Assoc; 2004; 40(4):292-9. PubMed ID: 15238559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome and toxicity associated with a dose-intensified, maintenance-free CHOP-based chemotherapy protocol in canine lymphoma: 130 cases.
    Sorenmo K; Overley B; Krick E; Ferrara T; LaBlanc A; Shofer F
    Vet Comp Oncol; 2010 Sep; 8(3):196-208. PubMed ID: 20691027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing first remission and survival in 145 dogs with lymphoma: a retrospective study.
    Baskin CR; Couto CG; Wittum TE
    J Am Anim Hosp Assoc; 2000; 36(5):404-9. PubMed ID: 10997515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma.
    Vail DM; Kisseberth WC; Obradovich JE; Moore FM; London CA; MacEwen EG; Ritter MA
    Exp Hematol; 1996 Jun; 24(7):807-15. PubMed ID: 8647231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a high-dose chemotherapy protocol with no maintenance therapy for dogs with lymphoma.
    Chun R; Garrett LD; Vail DM
    J Vet Intern Med; 2000; 14(2):120-4. PubMed ID: 10772481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a multi-agent chemotherapy protocol combining dexamethasone, melphalan, actinomycin D, and cytarabine for the treatment of resistant canine non-Hodgkin high-grade lymphomas: a single centre's experience.
    Smallwood K; Tanis JB; Grant IA; Blackwood L; Killick DR; Amores-Fuster I; Elliott J; Mas A; Harper A; Marrington M; Finotello R
    Vet Comp Oncol; 2019 Jun; 17(2):165-173. PubMed ID: 30666777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canine and feline lymphoma: challenges and opportunities for creating a paradigm shift.
    Argyle DJ; Pecceu E
    Vet Comp Oncol; 2016 Aug; 14 Suppl 1():1-7. PubMed ID: 27505685
    [No Abstract]   [Full Text] [Related]  

  • 14. Uric acid and phosphorus excretion in dogs with lymphosarcoma.
    Page RL; Leifer CE; Matus RE
    Am J Vet Res; 1986 Apr; 47(4):910-2. PubMed ID: 3754406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histologic classification as a prognostic criterion for canine lymphosarcoma.
    Weller RE; Holmberg CA; Theilen GH; Madewell BR
    Am J Vet Res; 1980 Aug; 41(8):1310-4. PubMed ID: 6893792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of feline intermediate- to high-grade lymphoma with a modified university of Wisconsin-Madison protocol: 119 cases (2004-2012).
    Collette SA; Allstadt SD; Chon EM; Vernau W; Smith AN; Garrett LD; Choy K; Rebhun RB; Rodriguez CO; Skorupski KA
    Vet Comp Oncol; 2016 Aug; 14 Suppl 1(Suppl 1):136-46. PubMed ID: 26109275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic variables in canine multicentric lymphosarcoma.
    Dobson JM; Blackwood LB; McInnes EF; Bostock DE; Nicholls P; Hoather TM; Tom BD
    J Small Anim Pract; 2001 Aug; 42(8):377-84. PubMed ID: 11518416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CHOP chemotherapy for the treatment of canine multicentric T-cell lymphoma.
    Rebhun RB; Kent MS; Borrofka SA; Frazier S; Skorupski K; Rodriguez CO
    Vet Comp Oncol; 2011 Mar; 9(1):38-44. PubMed ID: 21303452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapeutic responses in dogs with lymphosarcoma and hypercalcemia.
    Weller RE; Theilen GH; Madewell BR
    J Am Vet Med Assoc; 1982 Nov; 181(9):891-3. PubMed ID: 6897239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II clinical trial of combination chemotherapy with dexamethasone for lymphoma in dogs.
    Greenberg CB; Boria PA; Borgatti-Jeffreys A; Raskin RE; Lucroy MD
    J Am Anim Hosp Assoc; 2007; 43(1):27-32. PubMed ID: 17209082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.